Multimex Injection

Adult administration

Children over 11 years and adults: Dissolve 5 mL of this medication with injectable distilled water by gently shaking, and then mix it with 500 to 1,000 mL of intravenous dextrose injection, saline injection, or similar parenteral solutions within 5 minutes for intravenous drip administration once a day.

Child administration

Children over 11 years: Dissolve 5 mL of this medication with injectable distilled water by gently shaking, and then mix it with 500 to 1,000 mL of intravenous dextrose injection, saline injection, or similar parenteral solutions within 5 minutes for intravenous administration.

This medication should be used with caution in women within the first 3 months of pregnancy or those who may become pregnant, as administering more than 5,000 IU of vitamin A may pose a risk of congenital disabilities. Patients with hypersensitivity to the ingredients in this medication or patients with hemophilia should not use this medication. In patients with hypercalcemia or impaired renal function, the vitamin D in this medication may raise blood calcium levels and worsen the condition, so it should be administered cautiously. Precautions are also necessary for children over 11 years old, allergic individuals, and those with a history of drug hypersensitivity. In case of overdose, hypersensitivity reactions or severe allergic reactions such as anaphylaxis to vitamins A and D may occur, so symptoms should be monitored and administration should be discontinued immediately if any adverse effects appear. Long-term administration may lead to accumulation of vitamins A and D in the body, so regular check-ups are important. This medication may interact with specific drugs, and there may be cases when it should not be used together; therefore, patients must inform healthcare providers of any medications they are taking. Pregnant or breastfeeding women should use this medication cautiously to avoid the risks of adverse effects from vitamin overdose, following a doctor's guidance. The safety and efficacy in children under 11 years have not been established, so its use should be avoided. Elderly patients may require dosage adjustments due to decreased bodily functions. This medication may affect certain clinical test results, so patients should inform healthcare providers about its use before testing. When using this medication, it should be used immediately after opening, and any remaining medication should be discarded, as it contains light-sensitive ingredients that require protection from light and refrigeration during storage. Injecting the undiluted solution directly may cause dizziness or fainting, so it must be appropriately diluted before use. Store out of reach of children, avoid freezing, and keep it in the original container.

Serious side effects

• Hypotension
• altered consciousness
• difficulty breathing
• shock
• symptoms of anaphylaxis

Mild side effects

• Hypotension
• altered consciousness
• cyanosis
• nausea
• chest discomfort
• facial flushing
• itching
• sweating
• dizziness
• fainting

This medication should be stored in a sealed container to prevent exposure to air or humidity, and it is important to maintain a storage temperature between 1 and 30 degrees Celsius. Therefore, it should be stored securely away from direct sunlight, high temperatures, and low temperatures.

Appearance

A freeze-dried injection containing yellow powder in a brown vial

Package unit

For domestic use - 5 vials/vial, For domestic use - 10 vials/vial, For domestic use - 100 vials/vial